Considering these observations together with our results, KRAS-mediated activation of the ERK–RSK pathway regulates not only EphA2 protein expression but also the phosphorylation of EphA2, which consequently results in high level expression of pS-EphA2 leading to cancer metastasis. The gene discussed is KRAS; the disease is cancer.